Mustika Ratu Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mustika Ratu Tbk. trades at Rp390 (market cap 163.5B, 269.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mustika Ratu Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| MRAT | SCPI | |
|---|---|---|
Market Cap | 163.5B | 104.4B |
Volume | 269.7K | — |
Lot | 2.7K | — |
Turnover | 104.15M | — |
Average Price | 386.18 | — |
Value | 104.15M | — |
Indicative Equilibrium Price | 390 | — |
Indicative Equilibrium Volume | 500 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Mustika Ratu, founded in March 14, 1978 is a producer of traditional herbs and cosmetic. the Mustika Ratu line of herbal products are efficacious for health and beauty.
Read more on MRAT →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →